Maria A. Cassera

Maria A. Cassera

Auto-generated profile, based on publicly available information

Maria A. Cassera

The Oregon Clinic, Portland, OR, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2011 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
ARArthur Rawlings
Arthur Rawlings
NSNathaniel J. Soper
Nathaniel J. Soper
BOBrant Oelschlager
Brant Oelschlager
LSLee Swanstrom
Lee Swanstrom
BMBrent D. Matthews
Brent D. Matthews
LBL. Michael Brunt
L. Michael Brunt

1 July 2011 in Annals of Surgery
Verified
Journal Article
Closed access
JMJun Ma
Jun Ma
MCMaria A. Cassera
Maria A. Cassera
GSGeorg O. Spaun
Georg O. Spaun
CHChet Hammill
Chet Hammill
PHPaul D. Hansen
Paul D. Hansen
SAShaghayegh Aliabadi-Wahle
Shaghayegh Aliabadi-Wahle
To compare short-term surgical outcomes and quality of life (QOL) between single-port laparoscopic cholecystectomy (SPLC) and classic 4-port laparoscopic cholecystectomy (CLC). There is significant interest in further reducing the trauma associated with surgical procedures. Although a number of observational studies have suggested that SPLC is a feasible alternative to CLC, there is a lack of data from randomized studies validating any benefit over CLC. Eligible patients were randomized to receive SPLC or CLC. Operative and perioperative outcomes, including cosmesis and QOL were analyzed. Forty-three patients were randomized to SPLC (n = 21) or CLC (n = 22). There were no significant differences between groups for most preoperative demographics, American Society of Anesthesiology score, gallstone characteristics, local inflammation, blood loss, or length of stay. Patients undergoing SPLC were older than those receiving CLC (57.3 years vs. 45.8 years, P < 0.05). Operative times for SPLC were greater than CLC (88.5 minutes vs. 44.8 minutes, P < 0.05). Overall and cosmetic satisfaction, QOL as determined by the SF-36 survey, postoperative complications, and post-operative pain scores between discharge and 2-week postoperative visit were not significantly different between groups. Wound infection rates were similar in both groups. The SPLC group contained 1 retained bile duct stone, 1-port site hernia, and 1 postoperative port site hemorrhage. SPLC procedure time was longer and incurred more complications than CLC without significant benefits in patient satisfaction, postoperative pain and QOL. SPLC may be offered in carefully selected patients. Larger randomized trials performed later in the learning curve with SPLC may identify more subtle advantages of one method over another.

15 December 2003 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
DSDennis W. Schultz
Dennis W. Schultz
MKMichael L. Klein
Michael L. Klein
AHAndrea J. Humpert
Andrea J. Humpert
CLChristina W. Luzier
Christina W. Luzier
VPVesna Persun
Vesna Persun
TATed S. Acott
Ted S. Acott
Age-related macular degeneration (AMD) is a common cause of severe vision loss. Identification of the genes involved in AMD will lead to a better understanding of this disease at the molecular level, which will eventually lead to early detection, prevention and treatment. Previously, we mapped the ARMD1 gene to 1q25–31 in a large family with AMD. Here, we narrow the ARMD1 locus to 14.9 Mb between LAMB2 and D1S3469, a region containing 50 known genes. Twenty candidate genes within this region were screened for mutations. Only one DNA variation, an A16,263G transition in exon 104 of HEMICENTIN-1, was found to segregate exclusively with the disease haplotype in members of this large family with AMD. This variation produces a non-conservative substitution of arginine for glutamine at amino acid position 5345 (Gln5345Arg). It was also identified in 11 other individuals, all of whom share a haplotype, which envelops HEMICENTIN-1, with the large AMD family. The affected status of all but one of those individuals conforms to the age-dependent penetrance observed in AMD. The amino acid at position 5345 of HEMICENTIN-1 was conserved as glutamine in eight species analyzed. RT–PCR analysis demonstrated that exon 104 of HEMICENTIN-1 is alternatively spliced in various cell types. Exclusive segregation of Gln5345Arg with the disease haplotype in this large family, amino acid conservation of glutamine at this position among mammals, the non-conservative nature of the substitution and similarities to EFEMP1 support the conclusion that HEMICENTIN-1 is the ARMD1 gene.

9 August 2014 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
ESEran Shlomovitz
Eran Shlomovitz
RPRadu Pescarus
Radu Pescarus
MCMaria A. Cassera
Maria A. Cassera
ASAhmed M. Sharata
Ahmed M. Sharata
KRKevin M. Reavis
Kevin M. Reavis
LSLee L. Swanström
Lee L. Swanström

21 August 2015 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
ASAmber L. Shada
Amber L. Shada
CDChristy M. Dunst
Christy M. Dunst
RPRadu Pescarus
Radu Pescarus
ESEmily A. Speer
Emily A. Speer
MCMaria Cassera
Maria Cassera
LSLee L. Swanstrom
Lee L. Swanstrom

1 September 2012 in The American Journal of Surgery
Verified
Journal Article
Closed access
CEC. Kristian Enestvedt
C. Kristian Enestvedt
BDBrian S. Diggs
Brian S. Diggs
MCMaria A. Cassera
Maria A. Cassera
CHChet Hammill
Chet Hammill
PHPaul D. Hansen
Paul D. Hansen
RWRonald F. Wolf
Ronald F. Wolf